Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.76 USD | +1.33% | +2.63% | -36.87% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Financials (USD)
Sales 2024 * | 37.58M | Sales 2025 * | 135M | Capitalization | 817M |
---|---|---|---|---|---|
Net income 2024 * | -397M | Net income 2025 * | -314M | EV / Sales 2024 * | 8.22 x |
Net cash position 2024 * | 509M | Net cash position 2025 * | 337M | EV / Sales 2025 * | 3.57 x |
P/E ratio 2024 * |
-2.05
x | P/E ratio 2025 * |
-2.66
x | Employees | 487 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.33% |
Latest transcript on Sage Therapeutics, Inc.
1 day | -3.00% | ||
1 week | +4.18% | ||
Current month | -27.53% | ||
1 month | -27.34% | ||
3 months | -48.31% | ||
6 months | -25.79% | ||
Current year | -37.33% |
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 16 M€ | -8.49% | ||
0.21% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 13.68 | +0.74% | 473 288 |
24-04-25 | 13.58 | -3.00% | 1,414,569 |
24-04-24 | 14 | +8.11% | 2,521,967 |
24-04-23 | 12.95 | +0.47% | 815,185 |
24-04-22 | 12.89 | -3.30% | 803,340 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.33% | 817M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.73% | 22.02B | |
-17.84% | 20.9B | |
-9.28% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- SAGE Stock